Information Journal Paper
APA:
Copy. (2018). Reversal of resistance in targeted therapy of metastatic melanoma: lessons learned from vemurafenib (BRAF(V600E)-specific inhibitor). CANCERS, 10(-), 0-0. SID. https://sid.ir/paper/728981/en
Vancouver:
Copy. Reversal of resistance in targeted therapy of metastatic melanoma: lessons learned from vemurafenib (BRAF(V600E)-specific inhibitor). CANCERS[Internet]. 2018;10(-):0-0. Available from: https://sid.ir/paper/728981/en
IEEE:
Copy, “Reversal of resistance in targeted therapy of metastatic melanoma: lessons learned from vemurafenib (BRAF(V600E)-specific inhibitor),” CANCERS, vol. 10, no. -, pp. 0–0, 2018, [Online]. Available: https://sid.ir/paper/728981/en